Loading the section
Closing prices for September 17, 2026
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 17, 2026 | 76.42 | 79.94 | 75.00 | 76.97 | 3m |
| September 16, 2026 | 74.50 | 77.87 | 71.44 | 72.68 | 4m |
| September 15, 2026 | 70.13 | 75.61 | 70.11 | 74.39 | 3m |
| September 14, 2026 | 67.04 | 70.46 |
Based on reports through December 31, 2025
10x Genomics, Inc. (TXG) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 642.8m $, net income was -43.5m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588, US
| 246m |
| RVTYRevvity, Inc. | 146.73 | +0.69 % | 216m |
| BRKRBruker Corporation | 63.35 | +440.90 % | 121m |
| AVTRAvantor, Inc. | 15.86 | +1.60 % | 103m |
| BIOBio-Rad Laboratories, Inc. | 382.41 | +0.89 % | 95m |
| 64.73 |
| 70.11 |
| 3m |
| September 11, 2026 | 67.40 | 69.67 | 67.00 | 68.59 | 2m |
| September 10, 2026 | 65.17 | 67.70 | 64.03 | 66.38 | 2m |
| September 09, 2026 | 64.01 | 67.62 | 63.50 | 67.29 | 3m |
| September 08, 2026 | 61.36 | 66.03 | 61.36 | 65.60 | 3m |
| September 04, 2026 | 62.54 | 63.48 | 60.99 | 62.65 | 1m |
| September 03, 2026 | 62.35 | 63.89 | 60.35 | 63.22 | 2m |
| September 02, 2026 | 60.24 | 63.49 | 59.41 | 61.65 | 2m |
| September 01, 2026 | 61.79 | 62.33 | 59.76 | 59.98 | 2m |
| August 31, 2026 | 60.53 | 62.64 | 58.70 | 62.45 | 3m |
| August 28, 2026 | 63.88 | 65.00 | 60.82 | 61.54 | 2m |
| August 27, 2026 | 64.10 | 65.74 | 63.00 | 64.85 | 2m |
| August 26, 2026 | 63.69 | 65.26 | 62.42 | 64.26 | 3m |
| August 25, 2026 | 64.20 | 66.94 | 62.51 | 64.72 | 4m |
| August 24, 2026 | 63.15 | 64.38 | 60.93 | 63.80 | 4m |
| August 21, 2026 | 64.39 | 65.47 | 61.75 | 65.12 | 3m |
| August 20, 2026 | 60.70 | 64.53 | 60.70 | 63.87 | 3m |